These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8895775)

  • 1. Towards anti-Pseudomonas aeruginosa adhesion therapy.
    Gilboa-Garber N
    Adv Exp Med Biol; 1996; 408():39-50. PubMed ID: 8895775
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence of Pseudomonas aeruginosa and Candida albicans to glycosphingolipid (Asialo-GM1) receptors is achieved by a conserved receptor-binding domain present on their adhesins.
    Yu L; Lee KK; Hodges RS; Paranchych W; Irvin RT
    Infect Immun; 1994 Dec; 62(12):5213-9. PubMed ID: 7525482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of the lectins from Pseudomonas aeruginosa: insight into the molecular basis for host glycan recognition.
    Imberty A; wimmerová M; Mitchell EP; Gilboa-Garber N
    Microbes Infect; 2004 Feb; 6(2):221-8. PubMed ID: 15049333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model.
    Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
    J Cyst Fibros; 2016 Mar; 15(2):171-8. PubMed ID: 26303991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemagglutinating activities of Pseudomonas aeruginosa lectins PA-IL and PA-IIL exhibit opposite temperature profiles due to different receptor types.
    Gilboa-Garber N; Sudakevitz D
    FEMS Immunol Med Microbiol; 1999 Sep; 25(4):365-9. PubMed ID: 10497867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolides for the treatment of Pseudomonas aeruginosa infections?
    Howe RA; Spencer RC
    J Antimicrob Chemother; 1997 Aug; 40(2):153-5. PubMed ID: 9301978
    [No Abstract]   [Full Text] [Related]  

  • 8. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
    Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
    Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The protective effect of anti-Pseudomonas blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 2001; 47(6):55-7. PubMed ID: 11962093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of a peptide derived from a potential adhesin of Pseudomonas aeruginosa against corneal infection.
    Yuan Q; Wu Y; Wang Y; Chen L; Qu M; Duan K; Zhao G
    Exp Eye Res; 2016 Feb; 143():39-48. PubMed ID: 26500187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ; Hodges RS
    Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo inhibition of lectin mediated adhesion of Pseudomonas aeruginosa by receptor blocking carbohydrates.
    Ko HL; Beuth J; Sölter J; Schroten H; Uhlenbruck G; Pulverer G
    Infection; 1987; 15(4):237-40. PubMed ID: 3117698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice.
    Gholami M; Chirani AS; Razavi S; Falak R; Irajian G
    Lett Appl Microbiol; 2017 Nov; 65(5):439-445. PubMed ID: 28857243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and clinical manifestations of chronic colonization by Pseudomonas aeruginosa and its biofilms in the airway tract.
    Kobayashi H; Kobayashi O; Kawai S
    J Infect Chemother; 2009 Jun; 15(3):125-42. PubMed ID: 19554398
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.
    Boukerb AM; Rousset A; Galanos N; Méar JB; Thépaut M; Grandjean T; Gillon E; Cecioni S; Abderrahmen C; Faure K; Redelberger D; Kipnis E; Dessein R; Havet S; Darblade B; Matthews SE; de Bentzmann S; Guéry B; Cournoyer B; Imberty A; Vidal S
    J Med Chem; 2014 Dec; 57(24):10275-89. PubMed ID: 25419855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Donor plasma with anti-Pseudomonas aeruginosa activity as a directed-action preparation].
    Nazarchuk LV
    Vrach Delo; 1987 Jul; (7):96-8. PubMed ID: 3114958
    [No Abstract]   [Full Text] [Related]  

  • 18. Lectin-mediated bacterial adhesion to human tissue.
    Beuth J; Ko HL; Uhlenbruck G; Pulverer G
    Eur J Clin Microbiol; 1987 Oct; 6(5):591-3. PubMed ID: 3125051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.
    Markham RB; Pier GB; Schreiber JR
    J Immunol; 1991 Jan; 146(1):316-20. PubMed ID: 1898604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients.
    Pier GB
    J Infect Dis; 1996 Feb; 173(2):513-5. PubMed ID: 8568328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.